Dr. Chi-yuan Hsu, Division Chief of UCSF Nephrology, and Dr. Raymond Hsu (unrelated) co-authored an invited commentary in Annals of Internal Medicine's ACP Journal Club on the recently published TESTING [Therapeutic Effects of Steroids in IgA Nephropathy Global] study comparing oral methylprednisolone and placebo in kidney outcomes in IgA Nephropathy.